Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 21, 2026, titled "Glenmark Receives U.S. FDA Approval to Expand the Use of RYALTRIS® Nasal Spray for Children Aged 6 to Less Than 12 Years".
Glenmark Pharmaceuticals Limited Press Release Jul 21 2026
Earlier from Glenmark Pharmaceuticals
- Glenmark Pharmaceuticals Limited Press Release Jul 06 2026
- Glenmark Pharmaceuticals Limited Press Release Jul 02 2026
- Glenmark Pharmaceuticals Limited Press Release Jun 17 2026
- Glenmark Pharmaceuticals Limited Press Release Jun 11 2026